http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005019451-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9019c0ce5cb7b82c85e121f6cac86dce http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2f71c219deddcdd66e0eb4b86b91993 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate | 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fc605f74ec1cc8f11c6da60d313f3b1 |
| publicationDate | 2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2005019451-A1 |
| titleOfInvention | Nucleic acid construct for expressing pdk-1 activity inhibitor |
| abstract | It is intended to provide a means of regulating the phosphorylation activity of PDK-1 and a means of treating diseases caused by disorder in this activity. A nucleic acid construct for expressing an inhibitor of 3-phosphoinositide-dependent protein kinase 1 activity which contains a nucleic acid encoding a substance capable of inhibiting the activity of the phosphoinositide-dependent protein kinase 1 in vivo; a support for the expression of an inhibitor of 3-phosphoinositide-dependent protein kinase 1 activity in a mammalian cell which carries the nucleic acid construct for the expression as described above; a remedy and a therapeutic method for diseases caused by disorder in the phosphorylation activity of 3-phosphoinositide-dependent protein kinase 1 which contains the nucleic acid construct for the expression as described above or the support for the expression as described above as the active ingredient; and the nucleic acid construct for the expression as described above or the support for the expression as described above aiming at the production of a medicinal composition for the above diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013109142-A1 |
| priorityDate | 2003-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.